268 related articles for article (PubMed ID: 12668856)
1. Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries.
Goldschmidt-Clermont PJ
J Invasive Cardiol; 2002 Dec; 14 Suppl E():1E. PubMed ID: 12668856
[No Abstract] [Full Text] [Related]
2. Platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary revascularization: what more needs to be proven?
Lincoff AM; Topol EJ
Eur Heart J; 2000 Jun; 21(11):863-7. PubMed ID: 10806004
[No Abstract] [Full Text] [Related]
3. [Glycoprotein IIb/IIIa antagonists].
Hennemann A
Med Monatsschr Pharm; 2000 Dec; 23(12):385-90. PubMed ID: 11147193
[No Abstract] [Full Text] [Related]
4. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
Gambassi G; Landolfi R; Bernabei R
N Engl J Med; 1997 Oct; 337(17):1243-4. PubMed ID: 9340528
[No Abstract] [Full Text] [Related]
5. IIb/IIIa platelet inhibitors in the management of coronary artery disease.
Talley JD
J Ark Med Soc; 1996 Oct; 93(5):237-9. PubMed ID: 8908943
[No Abstract] [Full Text] [Related]
6. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
Khan SS; Forrester J
N Engl J Med; 1997 Oct; 337(17):1243; author reply 1244-5. PubMed ID: 9340527
[No Abstract] [Full Text] [Related]
7. Post-procedural patient management: prevention and management of bleeding complications.
Aguirre F
J Invasive Cardiol; 1994; 6 Suppl A():34A-37A; discussion 54A-56A. PubMed ID: 10155093
[No Abstract] [Full Text] [Related]
8. Ischemic coronary syndromes and SVG Interventions--do 2b/3a inhibitors miss the target?
Topaz O
Catheter Cardiovasc Interv; 2007 Apr; 69(5):630-1. PubMed ID: 17377986
[No Abstract] [Full Text] [Related]
9. Care of the patient receiving ReoPro following angioplasty.
Brezina K; Murphy M; Stonner T
J Invasive Cardiol; 1994; 6 Suppl A():38A-42A; discussion 54A-56A. PubMed ID: 10155094
[No Abstract] [Full Text] [Related]
10. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
[TBL] [Abstract][Full Text] [Related]
11. [Theombolysis with GP IIb/IIIa-receptor blockader. Platelt aggregation inhibition: clear indications, new strategies].
Internist (Berl); 1998 Dec; 39(12 Suppl Plattchena):1-4. PubMed ID: 10101692
[No Abstract] [Full Text] [Related]
12. Interventional therapy for coronary artery disease.
Shah PB; Lilly CM
Am J Respir Crit Care Med; 2002 Sep; 166(6):791-6. PubMed ID: 12231486
[No Abstract] [Full Text] [Related]
13. Local delivery of glycoprotein IIb/IIIa receptor inhibitors using drug eluting stents.
Gershlick AH
Semin Interv Cardiol; 1998; 3(3-4):185-90. PubMed ID: 10406691
[No Abstract] [Full Text] [Related]
14. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
Mukherjee D; Roffi M
J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343
[No Abstract] [Full Text] [Related]
15. Diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa blockade: the triad revisited.
Tang WH; Lincoff AM
Circulation; 2004 Dec; 110(24):3618-20. PubMed ID: 15596556
[No Abstract] [Full Text] [Related]
16. Minimally invasive bypass surgery.
Dragu RE
N Engl J Med; 2002 Dec; 347(26):2165-8; author reply 2165-8. PubMed ID: 12501850
[No Abstract] [Full Text] [Related]
17. Platelet glycoprotein IIb/IIIa antagonists in percutaneous coronary interventions.
Gambhir DS; Mukhopadhyay S
Indian Heart J; 2000; 52(5):524-32. PubMed ID: 11256774
[No Abstract] [Full Text] [Related]
18. Effect of glycoprotein IIb-IIIa receptor antagonism on platelet membrane glycoproteins after coronary stent placement.
Gawaz M; Ruf A; Neumann FJ; Pogátsa-Murray G; Dickfeld T; Zohlnhöfer D; Schömig A
Thromb Haemost; 1998 Dec; 80(6):994-1001. PubMed ID: 9869173
[TBL] [Abstract][Full Text] [Related]
19. Early and late clinical outcome following coronary angioplasty performed with platelet glycoprotein IIb/IIIa receptor inhibition: the EPIC Trial results.
Popma JJ; Satler LF
J Invasive Cardiol; 1994; 6 Suppl A():19A-28A; discussion 45A-50A. PubMed ID: 10155090
[TBL] [Abstract][Full Text] [Related]
20. Is heparin still necessary after primary angioplasty in the era of platelet glycoprotein IIb/IIIa receptor inhibitors? A review of the literature.
Lettieri C; De Servi S; Buffoli F; Aroldi M; Baccaglioni N; Romano M; Tomasi L; Izzo A; Zanini R
J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):653-9. PubMed ID: 16932077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
